A licensed drug presumably/hopefully has to conform to a strict specification of what it is, and what variations from nominal are allowable for it to still be marketable and prescribable as that drug. If some company attempted to market something significantly different from that drug under the same name/description, then surely that would be illegal. This should surely be the same for treatments that are pushed as if they are the same, such as CBT. Yet as we know, CBT applied in PACE, and pushed out across the world for PwME, is very different, yet its 'pushers' are more than happy to let the myth persist it is the same as normal CBT. At the very least it is unethical, but is there any way it could be construed illegal, or at least violating some medical practice code in doing that? It just seems like an absurd con trick, that if you take the drug analogy, would be just that. If you were to buy aspirins and they were not, then surely that would be sanctionable? @Jonathan Edwards, @dave30th, et al ?